2-Thiazolylimino/Heteroarylimino-5-arylidene-4-thiazolidinones as New Agents with SHP-2 Inhibitory Action-Reference-Cited by-同舟云学术

2-Thiazolylimino/Heteroarylimino-5-arylidene-4-thiazolidinones as New Agents with SHP-2 Inhibitory Action

Published:2008-08-15 Issue:17 Volume:51 Page:5221-5228
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Geronikaki A.¹,Eleftheriou P.¹,Vicini P.¹,Alam I.¹,Dixit A.¹,Saxena A. K.¹

Affiliation:

1. Department of Pharmaceutical Chemistry, School of Pharmacy, Aristotle University, Thessaloniki 54124, Greece, Dipartimento Farmaceutico, University of Parma, Parma 43100, Italy, and Medicinal Chemistry Division, Central Drug Research Institute, Chattar Manzil Palace, Lucknow-226 001, India

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm8004306

Reference37 articles.

1. Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction

2. The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

3. Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease

4. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

5. Diverse Biochemical Properties of Shp2 Mutants

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benzothiazole‐Piperazine Hybrids Effectively Target C4‐2 Castration‐Resistant Prostate Cancer Cells in vitro Implicated through Computational Studies;ChemistrySelect;2024-07-15

2. Synthesis, characterization, DFT, antibacterial, ADME-T properties, and molecular docking of new N-functionalized thiazolidinones;Journal of Molecular Structure;2024-07

3. A Facile, Mechanochemical, Solvent-, and Catalyst-Free Synthesis of Functionalized 4-Thiazolidinones;SynOpen;2023-10-12

4. Synthesis and antitumor activity of 1,3,4-oxadiazole substituted 2-(5-ylidene-2,4-dioxothiazolidin-3-yl)-acetamides;Pharmacia;2023-10-12

5. Development and validation of machine learning models for the prediction of SH-2 containing protein tyrosine phosphatase 2 inhibitors;Molecular Diversity;2023-08-08